Concepedia

Author

Anne S. R. van Lindert

University Medical Center UtrechtORCID

Also Known As

A. S. R. van Lindert, A.S.R. Van Lindert, A.S.R. van Lindert, ANNE S.R. VAN LINDERT, Anne S R van Lindert, Anne S. R. Lindert, Anne S. R. van Lindert, Anne S.R. Lindert, Anne S.R. van Lindert, Anne S.R. van Lindert

39

Publications

802

Citations

13

H-Index

26

Concepts

All Affiliations

University Medical Center UtrechtUtrecht UniversityThe Netherlands Cancer InstituteUniversity of GroningenRadboud University Medical Center
AS

About

Anne S. R. van Lindert is an author at University Medical Center Utrecht specializing in medicine, public health, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

357

2

Public Health

2

2

345

3

Health Sciences

1

1

12

4

Epidemiology

1

1

77

5

Global Health

1

1

77

Anne S. R. van Lindert

×

13

Publications

641

Citations

11

H-Index

YearCitations

Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease

Petra M. Gorter, Anne S. R. van Lindert, Alexander M. de Vos,

Atherosclerosis

2007

268

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol,

European Journal of Cancer

2020

77

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer

Chantal C. H. J. Kuijpers, Lizza Hendriks, Jules L. Derks,

Lung Cancer

2018

65

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations

Bart Koopman, Harry J.M. Groen, Marjolijn J. L. Ligtenberg,

The Oncologist

2020

45

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

Corine de Jong, Najiba Chargi, Gerarda J.M. Herder,

Journal of Cachexia Sarcopenia and Muscle

2022

43

Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy

Joyce E. Lodeweges, Peter S.N. van Rossum, M. Bartels,

Acta Oncologica

2021

37

Physical activity and checkpoint inhibition: association with toxicity and survival

Rik J. Verheijden, Anna Cabané Ballester, Karel C Smit,

JNCI Journal of the National Cancer Institute

2023

24

Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition

Mick J M van Eijs, Rik J. Verheijden, Stefanie A. van der Wees,

Cancer Immunology Immunotherapy

2023

22

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer

Robert D. Schouten, Daan C.L. Vessies, Linda J.W. Bosch,

JCO Precision Oncology

2021

14

Considerable interlaboratory variation in PD-L1 positivity in a nationwide cohort of non-small cell lung cancer patients

Bregje M Koomen, Quirinus J.M. Voorham, Chantal C. H. J. Epskamp-Kuijpers,

Lung Cancer

2021

13

Page 1